Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
Create a narrative
Hikal Community
BSE:524735 Community
1
Narratives
written by author
0
Comments
on narratives written by author
2
Fair Values set
on narratives written by author
Create a narrative
Hikal
Popular
Undervalued
Overvalued
Community Investing Ideas
Hikal
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Project Pinnacle Will Improve Cost Efficiency And Support Sustainability
Key Takeaways Expansion in the API and CDMO segments is anticipated to drive revenue growth and improve margins through new products and geographical reach. Project Pinnacle's focus on operational excellence and sustainability is expected to enhance cost efficiency and support long-term earnings growth.
View narrative
₹450.00
FV
11.6% undervalued
intrinsic discount
13.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
524735
524735
Hikal
Your Fair Value
₹
Current Price
₹397.75
34.6% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
34b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹34.2b
Earnings ₹1.4b
Advanced
Set Fair Value